Multi-site malaria microscopy with artificial intelligence (AI) faces a structural tension: diagnostic parity across sites requires models trained on staining variation, yet patient privacy and data-sovereignty rules prevent the central pooling of slide images. Federated learning (FL) is proposed as a resolution, but its utility under realistic staining heterogeneity has not been characterised in a way that separates privacy protection from diagnostic cost. the present analysis develops a formal framework for evaluating FL under variable Giemsa staining protocols, treating stain variation as a domain shift that decomposes into a site-specific colour-appearance component and a shared morphological component. We derive a federated averaging bound that isolates the contribution of stain-induced feature divergence to diagnostic parity loss, and we specify a privacy-utility frontier that makes the trade-off between differential-privacy noise and diagnostic agreement explicit. The framework is operationalised as a design-evaluation protocol with declared variance components (between-cluster SD = 6.0, residual SD = 4.5, intraclass correlation = 0.64) and a replication-based power analysis across 2000 design cells. The analysis characterises the operating characteristics of a before-after-control-impact evaluation of FL diagnostic parity, identifying the cluster counts at which a five-percentage-point parity effect is detectable at 80% power. The contribution is a specification of the conditions under which FL can be expected to deliver diagnostic parity without central data pooling, and a statement of the boundary conditions under which stain heterogeneity overwhelms the privacy benefit.
No takes yet. Share an insight, caveat, or question.
Koyagbélé et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: